Sigyn Therapeutics Inc
(SIGY)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 322 | 8 | 28 | 7 | 81 |
| Inventories | 50 | 50 | 50 | 50 | 50 |
| Other current assets | 40 | 12 | 7 | 48 | 12 |
| TOTAL | $413 | $70 | $85 | $105 | $144 |
| Non-Current Assets | |||||
| PPE Net | 20 | 22 | 24 | 26 | 263 |
| Intangibles | 1 | 2 | 3 | 4 | 5 |
| Other Non-Current Assets | 227 | 238 | 250 | 262 | 273 |
| TOTAL | $248 | $263 | $277 | $291 | $541 |
| Total Assets | $660 | $333 | $362 | $396 | $447 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 2,471 | 1,637 | 1,515 | 945 | 705 |
| Accounts payable and accrued liabilities | 265 | 328 | 306 | 299 | 196 |
| Accrued Expenses | 41 | 30 | 30 | 70 | N/A |
| Other current liabilities | 1 | 1 | N/A | N/A | 2 |
| TOTAL | $2,833 | $2,049 | $1,903 | $1,364 | $951 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 173 | 187 | 202 | 215 | 228 |
| TOTAL | $173 | $187 | $202 | $215 | $228 |
| Total Liabilities | $3,007 | $2,236 | $2,104 | $1,579 | $1,179 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,075 | 1,068 | 932 | 932 | 932 |
| Common Shares | 4 | 0 | 4 | 4 | 4 |
| Retained earnings | -8,537 | -7,196 | -6,337 | -5,610 | -4,944 |
| TOTAL | $-2,346 | $-1,903 | $-1,742 | $-1,183 | $-732 |
| Total Liabilities And Equity | $661 | $333 | $362 | $396 | $447 |